Siemens Couples a Bigger Payout With a Smaller Core

Siemens is asking shareholders to back a payout package that hands them a slice of Siemens Healthineers while the industrial group simultaneously trims its own earnings base. The proposal, which pairs a higher cash dividend with an in-specie distribution of Healthineers stock, will go to votes at both companies in February 2027.

Under the plan, 34.1% of Healthineers shares would be transferred to Siemens investors in May 2027 at a ratio of one Healthineers share for every two Siemens shares held. Siemens would retain a one-third stake afterwards, a step designed to deconsolidate the diagnostics and imaging unit from its accounts. The cash component is a proposed dividend of €5.50 per share, on which the next annual general meeting will vote.

Cash generation underwrites the plan

What gives the group room to keep paying out through the restructuring is its internal funding. Free cash flow hit a record €12.1 billion in fiscal 2026. A decline in net income for the year is largely explained by a prior-year one-off: the sale of Innomotics had lifted the comparable figure. The industrial business, by contrast, turned in a record result, so operating momentum and cash generation both matter when judging the sustainability of the distribution.

Management is also raising its sights. For fiscal 2027, Siemens is guiding to comparable revenue growth of 9% to 11%, a forecast that excludes Healthineers. Earnings per share before purchase price allocation effects, or EPS pre PPA, are projected at €10.20 to €10.80. Over the medium term the bar moves higher still: comparable revenue growth of 7% to 11%, up from a previous 6% to 9%, and double-digit growth in EPS pre PPA.

Order book sets a record

The growth targets rest on unusually strong demand. Siemens reported a record order intake for fiscal 2026, with comparable orders climbing 25% to €108.2 billion. Morningstar analysts consider the upgraded medium-term goals achievable given that backlog, pointing to digitalisation and the energy transition as tailwinds, along with recurring maintenance and upgrade revenue from the installed industrial base. The caveat is execution: the order book only pays off if it converts into profitable revenue.

Morningstar also wants clarity on the long-term role of the Healthineers holding. Further monetisation of the stake to fund software acquisitions raises strategic questions, meaning the benefits of the reshaped group will hinge partly on whether such deals strengthen earnings power over time.

Bolt-ons broaden the technology base

Siemens has been adding capability on several fronts. On Tuesday it signed an agreement to acquire Lauterbach GmbH, folding debug and trace technology for embedded software and complex SoC architectures into its semiconductor design and verification portfolio. The company expects to close the deal in the first half of 2027, subject to customary conditions and approvals; financial terms were not disclosed.

A day earlier, Siemens struck a six-year contract with Kärnten Netz GmbH to supply its Gridscale X grid software, a platform covering both network planning and network management, including the low-voltage grid. On the rail side, Siemens Mobility opened a manufacturing and research centre for rail infrastructure in Chippenham on 6 November, an investment the group put at €115 million.

For investors, the appeal of the package comes down to two tests: whether the remaining Siemens businesses deliver on their growth targets, and whether the group keeps generating the free cash flow that has funded its payouts so far.